Reuters
Since its spinoff from Johnson & Johnson in May last year, Kenvue has focused on its 15 priority brands to boost growth and said in February it would increase its advertising spending by 15%, or about $300 million, during the year. The self-care segment - which includes cough and cold medicine such as Tylenol and Benadryl - recorded $1.70 billion in net sales, up 3.5% year-on-year and above the average analyst estimate of $1.56 billion, according to LSEG data. Kenvue's skin health and beauty segment, consisting of brands including Neutrogena and Clean & Clear, recorded a 5% drop in first-quarter sales to $1.05 billion, but largely in line with estimates.